Journal of the American College of Cardiology, ISSN 0735-1097, 08/2017, Volume 70, Issue 6, pp. 776 - 803
Table of Contents Preamble777 Introduction779 Methodology and Evidence Review779 Organization of the Writing Group779 Document Review and Approval779 Initial...
ACC/AHA Clinical Practice Guidelines | heart failure | angiotensin-converting enzyme inhibitors | angiotensin receptor blockers | ferric carboxymaltose | beta blockers | angiotensin receptor-neprilysin inhibitor | angioedema | natriuretic peptides | focused update | ivabradine | iron deficiency | hypertension | sleep apnea | natriuretic peptide biomarker | United States | Humans | Heart Failure - physiopathology | Heart Failure - metabolism | Cardiology - standards | Secondary Prevention - methods | Advisory Committees | Cardiovascular Agents - pharmacology | American Heart Association | Stroke Volume | Heart Failure - therapy | Renin-Angiotensin System - drug effects | Research Report | Heart Failure - etiology | Heart failure | Hypertension | Heart | Medical services | Cardiovascular disease | Sleep apnea | Pharmacology | Blood | Guidelines | Disease prevention | Studies | Randomization | Sleep | Converting | Medical prognosis | Biomarkers | Blood pressure | Clinical medicine | Breathing | Cardiology | Heart diseases | Ejection
ACC/AHA Clinical Practice Guidelines | heart failure | angiotensin-converting enzyme inhibitors | angiotensin receptor blockers | ferric carboxymaltose | beta blockers | angiotensin receptor-neprilysin inhibitor | angioedema | natriuretic peptides | focused update | ivabradine | iron deficiency | hypertension | sleep apnea | natriuretic peptide biomarker | United States | Humans | Heart Failure - physiopathology | Heart Failure - metabolism | Cardiology - standards | Secondary Prevention - methods | Advisory Committees | Cardiovascular Agents - pharmacology | American Heart Association | Stroke Volume | Heart Failure - therapy | Renin-Angiotensin System - drug effects | Research Report | Heart Failure - etiology | Heart failure | Hypertension | Heart | Medical services | Cardiovascular disease | Sleep apnea | Pharmacology | Blood | Guidelines | Disease prevention | Studies | Randomization | Sleep | Converting | Medical prognosis | Biomarkers | Blood pressure | Clinical medicine | Breathing | Cardiology | Heart diseases | Ejection
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2016, Volume 68, Issue 13, pp. 1476 - 1488
Given the well-proven mortality benefits of beta-blocker therapy, it is important to initiate and up titrate these agents to target doses, as tolerated,...
ACC/AHA Clinical Practice Guidelines | angioedema | heart failure | natriuretic peptides | angiotensin-converting enzyme inhibitors | angiotensin receptor blockers | focused update | ivabradine | beta blockers | angiotensin receptor-neprilysin inhibitor | Heart failure | Task forces | Heart attacks | Physicians | Mortality | Colleges & universities | Disclosure | Gene expression | Patients | Heart rate | Sinuses | Quality | Writing | Clinical medicine | Peer review | Cardiology
ACC/AHA Clinical Practice Guidelines | angioedema | heart failure | natriuretic peptides | angiotensin-converting enzyme inhibitors | angiotensin receptor blockers | focused update | ivabradine | beta blockers | angiotensin receptor-neprilysin inhibitor | Heart failure | Task forces | Heart attacks | Physicians | Mortality | Colleges & universities | Disclosure | Gene expression | Patients | Heart rate | Sinuses | Quality | Writing | Clinical medicine | Peer review | Cardiology
Journal Article
Circulation, ISSN 0009-7322, 01/2013, Volume 127, Issue 4, pp. 529 - 555
Anticoagulants | AHA scientific statements | ST-elevation myocardial infarction | Reperfusion | Antiplatelets | Percutaneous coronary intervention | Door-to-balloon | Fibrinolysis | FREE-WALL RUPTURE | PERCUTANEOUS CORONARY INTERVENTION | ARTERY-BYPASS SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | INTRAAORTIC BALLOON COUNTERPULSATION | IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR | LEFT-VENTRICULAR DYSFUNCTION | PERIPHERAL VASCULAR DISEASE | HOSPITAL CARDIAC-ARREST | THROMBOLYTIC THERAPY | PRIMARY ANGIOPLASTY | CARDIOGENIC-SHOCK | Myocardial Infarction - diagnosis | Evidence-Based Medicine - methods | Myocardial Infarction - epidemiology | Risk Assessment | United States | Humans | Diagnostic Techniques, Cardiovascular | Cardiology - standards | Medication Therapy Management - standards | Myocardial Reperfusion - methods | Patient Selection | American Heart Association | Evidence-Based Medicine - standards | Myocardial Infarction - therapy | Emergency Medical Services - organization & administration | Thrombolytic Therapy | Electrocardiography | Disease Management | Emergency Medical Services - methods | Percutaneous Coronary Intervention | Cardiology - methods | Practice guidelines (Medicine) | Usage | Care and treatment | Conferences, meetings and seminars | Medical societies | Heart attack
Journal Article
Circulation, ISSN 0009-7322, 08/2012, Volume 126, Issue 7, pp. 875 - 910
Myocardial Infarction - diagnosis | Evidence-Based Medicine - methods | Myocardial Infarction - epidemiology | Risk Assessment | United States | Humans | Diagnostic Techniques, Cardiovascular | Clinical Protocols - standards | Cardiology - standards | Medication Therapy Management - standards | Myocardial Reperfusion - methods | Patient Selection | American Heart Association | Evidence-Based Medicine - standards | Myocardial Infarction - therapy | Emergency Medical Services - organization & administration | Thrombolytic Therapy | Electrocardiography | Clinical Protocols - classification | Disease Management | Emergency Medical Services - methods | Percutaneous Coronary Intervention | Cardiology - methods | Heart failure | Care and treatment | Usage | Conferences, meetings and seminars | Unstable angina | Medical societies | Practice guidelines (Medicine)
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2013, Volume 62, Issue 16, pp. 1495 - 1539
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2007, Volume 50, Issue 7, pp. e1 - e157
Journal Article
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, ISSN 1522-1946, 07/2013, Volume 82, Issue 1, pp. E1 - 27
Myocardial Infarction - diagnosis | Predictive Value of Tests | Myocardial Infarction - mortality | Risk Assessment | Percutaneous Coronary Intervention - mortality | Humans | Risk Factors | Anticoagulants - therapeutic use | Treatment Outcome | Cardiology - standards | Thrombolytic Therapy - mortality | Percutaneous Coronary Intervention - standards | Time-to-Treatment - standards | Coronary Artery Bypass - adverse effects | Myocardial Infarction - therapy | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Bypass - mortality | Coronary Angiography - standards | Coronary Artery Bypass - standards | Thrombolytic Therapy - standards | Platelet Aggregation Inhibitors - therapeutic use | Thrombolytic Therapy - adverse effects | Percutaneous Coronary Intervention - adverse effects | Stents - standards
Journal Article
Circulation, ISSN 0009-7322, 04/2009, Volume 119, Issue 14, pp. e391 - e479
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2007, Volume 49, Issue 6, pp. 734 - 739
Dual antiplatelet therapy with aspirin and a thienopyridine has been shown to reduce cardiac events after coronary stenting. However, many patients and...
thrombosis | myocardial stunning | stents | myocardial infarction | AHA Scientific Statements
thrombosis | myocardial stunning | stents | myocardial infarction | AHA Scientific Statements
Journal Article
JAMA Internal Medicine, ISSN 2168-6106, 09/2013, Volume 173, Issue 17, pp. 1581 - 1583
Journal Article
Circulation: Cardiovascular Quality and Outcomes, ISSN 1941-7713, 04/2019, Volume 12, Issue Suppl_1
Journal Article
Circulation, ISSN 0009-7322, 04/2009, Volume 119, Issue 14, pp. 1977 - 2016
American Heart Association | Heart Failure - therapy | Foundations | Lung Transplantation | Societies, Medical | United States | Humans | Adult | Heart Transplantation | Heart Failure - diagnosis | Heart failure | Usage | Care and treatment | Practice guidelines (Medicine) | Medical care | Diagnosis | Standards
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2007, Volume 50, Issue 7, pp. 652 - 726
Journal Article
American Journal of Medical Quality, ISSN 1062-8606, 9/2017, Volume 32, Issue 5, pp. 573 - 573
Journal Article
15.
Full Text
2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2019, Volume 74, Issue 21, pp. 2661 - 2706
Journal Article
16.
Full Text
Prochlorococcus contributes to new production in the Sargasso Sea deep chlorophyll maximum
Geophysical Research Letters, ISSN 0094-8276, 05/2007, Volume 34, Issue 10, pp. L10604 - n/a
Prochlorococcus is ubiquitous in tropical oceans, but its biogeochemical role is not well constrained. For example, cultured Prochlorococcus clones do not grow...
Microbiology and microbial ecology | Phytoplankton | Oceanography | Biogeochemical cycles, processes, and modeling | Nutrients and nutrient cycling | Biological and Chemical | Prochlorococcus | new production | iron limitation | CENTRAL ATLANTIC-OCEAN | TIME-SERIES STATION | ECOTYPES | GEOSCIENCES, MULTIDISCIPLINARY | NORTH-ATLANTIC | SYNECHOCOCCUS CELLS | UPTAKE RATES | CYANOBACTERIA | GROWTH | NITROGEN | PHYTOPLANKTON
Microbiology and microbial ecology | Phytoplankton | Oceanography | Biogeochemical cycles, processes, and modeling | Nutrients and nutrient cycling | Biological and Chemical | Prochlorococcus | new production | iron limitation | CENTRAL ATLANTIC-OCEAN | TIME-SERIES STATION | ECOTYPES | GEOSCIENCES, MULTIDISCIPLINARY | NORTH-ATLANTIC | SYNECHOCOCCUS CELLS | UPTAKE RATES | CYANOBACTERIA | GROWTH | NITROGEN | PHYTOPLANKTON
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2013, Volume 62, Issue 16, pp. e147 - e239
heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | BRAIN NATRIURETIC PEPTIDE | CV surgery: transplantation | MECHANICAL CIRCULATORY SUPPORT | other heart failure | ACCF/AHA Practice Guidelines | CARDIAC-RESYNCHRONIZATION THERAPY | ventricular assistance, cardiomyopathy | CONVERTING-ENZYME-INHIBITORS | epidemiology | LEFT-VENTRICULAR DYSFUNCTION | IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ACUTE MYOCARDIAL-INFARCTION | cardio-renal physiology/pathophysiology | congestive heart failure | PLACEBO-CONTROLLED TRIAL | CORONARY-ARTERY-DISEASE | health policy and outcome research | Heart Failure - therapy | Heart Failure - classification | Evidence-Based Practice | United States | Humans | Heart Failure - physiopathology | Adult | Disease Management | Heart Failure - diagnosis | Heart Failure - epidemiology | Heart Failure - etiology
Journal Article
JAMA Internal Medicine, ISSN 2168-6106, 09/2013, Volume 173, Issue 17, p. 1581
Journal Article
American Journal of Medical Quality, ISSN 1062-8606, 3/2018, Volume 33, Issue 2, pp. 219 - 220
Journal Article
20.
Full Text
Prochlorococcus contributes to new poduction in the Sargasso Sea deep chlorophyll maximum
Geophysical Research Letters, ISSN 0094-8276, 05/2007, Volume 34, Issue 10
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.